IN SILICO STUDY: ANTIDIABETIC POTENTIAL OF CHINESE BETEL (Peperomia pellucida) COMPOUNDS IDENTIFIED VIA GC-MS ANALYSIS AGAINST TYPE 2 DIABETES
STUDI IN SILICO: EFEKTIVITAS SENYAWA SIRIH CINA ANALISIS GC-MS SEBAGAI ANTI DIABETES TIPE 2
DOI:
https://doi.org/10.51771/fj.v6i02.2252Keywords:
T2DM, Peperomia pellucida L. Kunth, PPAR-γ, α-glucosidase, SGLT-2Abstract
Type 2 diabetes mellitus (T2DM) is a metabolic disease characterized by elevated blood glucose levels (hyperglycemia). According to the World Health Organization (WHO), the global prevalence of diabetes mellitus has continued to increase. This is consistent with the 2023 Indonesian Health Survey (SKI), which reported that the prevalence of type 2 diabetes mellitus in Indonesia reached 1.7%, representing an increase compared to the previous survey in 2018, which reported a prevalence of 1.5%. This condition necessitates the development of safer and more effective therapeutic alternatives. Therefore, this study aimed to identify the bioactive compounds of Peperomia pellucida (L.) Kunth leaves through GC-MS analysis and to evaluate their potential against T2DM target proteins, namely PPAR-γ, α-glucosidase, and SGLT-2, using an insilico approach. The GC-MS analysis identified phytol and dillapiole as the dominant compounds. Molecular docking results showed that no active compound exhibited a higher binding affinity than Rosiglitazone toward PPAR-γ. In contrast, for α-glucosidase, phytol, neophytadiene, and geranyllinalool demonstrated higher rerank scores than Miglitol, while dillapiole exhibited the highest similarity in interacting residues. For SGLT-2, several compounds, namely neophytadiene, geranyllinalool, and tetracosane, showed higher rerank scores than Empagliflozin. Lipinski's rule of five indicated that most compounds met the drug-likeness criteria, including dillapiole, caryophyllene, tadalafil, spathulenol, and lepidozene. Overall, these findings indicate that the bioactive compounds identified from the GC-MS analysis of Peperomia pellucida leaves have the potential to serve as antidiabetic candidates through a multitarget mechanism.
References
Adinortey, C. A., Kwarko, G. B., Koranteng, R., Boison, D., Obuaba, I., Wilson, M. D., & Kwofie, S. K. (2022). Molecular structure-based screening of the constituents of Calotropis procera identifies potential inhibitors of diabetes mellitus targ et al pha glucosidase. Current Issues in Molecular Biology, 44(2), 963–987
Amin, S., Farwah, S. L., Fathurrahman, R., & Kunci, K. (2025). Tinjauan Literatur: Pendekatan Komputasi dan Sintesis Turunan Flavonoid Sebagai Kandidat Obat Antidiabetes Tipe 2 Literature Review: Computational Approaches and Synthesis of Flavonoid Derivatives as Candidates for Type 2 Antidiabetic Drugs. 8(11), 7499–7508.
Amini, F., Abbas, K. I., & Ghasemi, J. B. (2025). Molecular modeling approach in design of new scaffold of α-glucosidase inhibitor as antidiabetic drug. Biochemistry and biophysics reports, 42, 101995.
Assett, R. L., Gallo, G., Le, K. P. N., et al . (2024). Bexagliflozin: A comprehensive review of a recently approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus. Medicinal Chemistry Research, 33, 1354–1367
Decroli, E. (2019). Diabetes melitus tipe 2. Padang: Pusat Penerbitan Bagian Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Andalas, 1–52
Devina, A. A., Halim, F. C., Meivi, M., Masulili, S. L. C., Tadjoedin, E. S. S., Lessang, R., Widaryono, A., Bachtiar, B. M., Sulijaya, B., & Tadjoedin, F. M. (2024). Effectiveness of 0.2% hyaluronic acid on clinical, biomolecular and microbiological parameters in type 2 diabetes mellitus patients with periodontitis. European Journal of Dentistry
Guo, J., Wei, M., Zhang, W., Jiang, Y., Li, A., Wang, C., Yin, D., Sun, A., & Gong, Y. (2025). Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials. Frontiers in Pharmacology, 16, 1517272
Hafidz, R., Ahwan, & Ariastuti, R. (2025). Uji kandungan fenolik total dan aktivitas antioksidan ekstrak etanol biji kelor (Moringa oleifera L.) dan daun sirih cina (Peperomia pellucida L.). Borobudur Pharmacy Review, 5(1), 1–8
Kementerian Kesehatan Republik Indonesia. (2023). Survei Kesehatan Indonesia (SKI) 2023. Jakarta: Kementerian Kesehatan RI
Kowalska, J., & Wrześniok, D. (2024). Skin-related adverse reactions induced by oral antidiabetic drugs—A review of literature and case reports. Pharmaceuticals, 17(7), 847.
Krisdayani, D., & Nugroho, C. A. (2025). Uji efektivitas ekstrak etanol tanaman sirih cina (Peperomia pellucida L. Kunth) sebagai antihiperglikemia pada mencit (Mus musculus L.) yang diinduksi glukosa. Biospektrum Jurnal Biologi, 6(1).
Krisdayani, D., & Nugroho, C. A. (2025). UJI EFEKTIVITAS EKSTRAK ETANOL TANAMAN SIRIH CINA (Peperomia pellucida L. Kunth) SEBAGAI ANTIHIPERGLIKEMIA PADA MENCIT (Mus musculus L.) YANG DIINDUKSI GLUKOSA. Biospektrum Jurnal Biologi, 6(1), 1–7.
Kroker, A. J., & Bruning, J. B. (2015). Review of the structural and dynamic mechanisms of PPARγ partial agonism. PPAR Research, 2015, 816856.
Lian, Y. E., Wang, M., Ma, L., Yi, W., Liao, S., Gao, H., & Zhou, Z. (2024). Identification of novel PPARγ partial agonists based on virtual screening strategy: In silico and in vitro experimental validation. Molecules, 29(20), 4881.
Lin, D. S. H., Lee, J. K., & Chen, W. J. (2021). Clinical adverse events associated with sodium–glucose cotransporter 2 inhibitors: A meta-analysis involving 10 randomized clinical trials and 71,553 individuals. The Journal of Clinical Endocrinology & Metabolism, 106(7), 2133–2145.
Lloyd, A., Austin-Muttitt, K., & Mullins, J. G. L. (2025). Computational structural studies of SGLT2-related polypharmacy. PLoS ONE, 20(10), e0334656.
Maharani, A., & Sholih, M. G. (2024). Literature review: Faktor risiko penyebab diabetes melitus tipe II pada remaja. Jurnal Sehat Mandiri, 19(1), 185–197
Mazoudji, A., & Ecker, G. F. (2025). Docking-based classification of SGLT2 inhibitors. Molecules, 30(10), 2179.
Misbah, Hayat, S., Ullah, H., Rahim, F., Gul, F. S., Rab, A., Iqbal, N., Taha, M., Sajid, M., & Abdelaziz, M. A. (2026). Thiadiazole-linked Schiff bases as promising α-glucosidase and α-amylase inhibitors: synthesis, molecular docking and ADME analysis. Chemical Data Collections, 62, 101223
Nicchio, I. G., Cirelli, T., Quil, L. C. da C., Camilli, A. C., Scarel-Caminaga, R. M., & Leite, F. R. M. (2025). Understanding the peroxisome proliferator-activated receptor gamma (PPAR-γ) role in periodontitis and diabetes mellitus: A molecular perspective. Biochemical Pharmacology, 237, 116908
Nurjannah, P., Yulia, R., & Nadia, S. (2026). ORIGINAL ARTICLE: Phytochemical Screening, GC-MS Analysis, and Antioxidant Activity (DPPH Method) of Ethanol Extract of Chinese Betel Leaf (Peperomia pellucida (L.) Kunth) Skrining Fitokimia, Analisis GC-MS, dan Aktivitas Antioksidan (Metode DPPH). 1791–1801.
Okto Supratman, Mualimah Hudatwi, & Indah Auliana. (2021). JBIO: Jurnal Biosains (The Journal of Biosciences). The Influence of Shiftwork on Liver Dysfunction of Workers at INALUM Company Kuala Anjung, North Sumatera. 7(3), 121–126.
Pratiwi, A., Datau, W. A., Alamri, Y., & Kandowangko, N. Y. (2021). Sebagai Teh Herbal Antidiabetes. Jambura Journal of Health Sciences and Research, 3(1), 85–93.
Rosalinda, J. D., Waluyo, J., & Kuswati. (2025). GC-MS Study of Bioactive Compounds of Peperomia pellucida and Its Antibacterial Activity against Streptococcus mutans. Journal of Biology and Applied Biology, 8(1), 83–94.
Saharun, N. N., Salma, W. O., & Muchtar, F. (2025). Pengaruh pemberian ekstrak tanaman sirih cina (Peperomia pellucida L. Kunth) terhadap penurunan kadar glukosa darah pada mencit (Mus musculus). Jurnal Kendari Kesehatan Masyarakat, 4(2)
Sapra, A., & Bhandari, P. (2023). Diabetes. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
Shamsudin, N. F., Ahmed, Q. U., Mahmood, S., Shah, S. A. A., Sarian, M. N., Khattak, M. M. A. K., Khatib, A., Sabere, A. S. M., Yusoff, Y. M., & Latip, J. (2022). Flavonoids as Antidiabetic and Anti-Inflammatory Agents: A Review on Structural Activity Relationship-Based Studies and Meta-Analysis. International Journal of Molecular Sciences, 23(20).
Tella, T., Pohl, C., & Kovalchuk, I. (2024). A review on diabetes mellitus: complications, synthetic anti-diabetic agents and herbal treatment. F1000Research, 13, 124
Thanishka, W. A. D. J., Dassanayake, D. M. W. L., Dimbulgahamada, D. M. S. R., Fernando, W. D. U. S., Dias, N. T. B., De Silva, H. H. V. K. N., & Samanmali, B. L. C. (2026). Formulation and in vitro evaluation of an anti-inflammatory herbal suppository containing Peperomia pellucida. Frontiers in Pharmacology, 17(February), 1–13.
Wanner, C., Iliev, H., Duarte, N., et al . (2024). Safety of empagliflozin: An individual participant-level data meta-analysis from four large trials. Advances in Therapy, 41, 2826–2844.
Wasni, N. Z., Harahap, A. M., & M, I. P. (2022). GCMS analysis of bioactive compounds of Chinese beat leaves (Peperromia pellucida) with extraction application using Soxhletation method. JBIO: Jurnal Biosains (The Journal of Biosciences), 8(3).
World Health Organization. (2024). Diabetes
Xiao, B., Su, M., Kim, E. L., Hong, J., Chung, H. Y., Kim, H. S., Yin, J., & Jung, J. H. (2014). Synthesis of PPAR-γ activators inspired by the marine natural product, paecilocin A. Marine Drugs, 12(2), 926–939.
Yerramneedi, R. B., Satapathy, P., Jigili, R., Padal, S. B., Rajesh Babu, Y. T., Krishna, C. M., & Ramalakshmana, J. (2023). GC-MS analysis and screening of antimicrobial potentialities of the medicinal herb Peperomia pellucida (L.) Kunth. Journal of Xidian University, 17(8), 1376–1389.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Vincensius Christian, Indra Priawan , Muhamad Satria Sanjaya Hutagalung, Christian Farrell Kosasih, Deva Dian Pramudya, Bintang Junior

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.



